Crossmark

Advances in Personalized Treatment and Prognostic Factors of Follicular Lymphoma

Crossref DOI link: https://doi.org/10.1007/s11864-025-01297-6

Published Online: 2025-04-02

Published Print: 2025-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Cheng, Shijia https://orcid.org/0009-0007-5766-4894
Liu, Yanyan https://orcid.org/0000-0002-3887-0840
License Information

Text and Data Mining valid from 2025-04-01

Version of Record valid from 2025-04-01
More Information

Article History

Accepted: 2 February 2025

First Online: 2 April 2025

Declarations

:

: The authors declare no competing interests.

: Not applicable.